Filter
948
Filtered Results: 948
Text search:
European
Public
Health
Alliance
Featured
Recommendations
70
New Publications
187
Language
Document type
No document type
435
Studies & Reports
265
Guidelines
101
Manuals
54
Strategic & Response Plan
46
Training Material
24
Fact sheets
8
Situation Updates
7
Brochures
3
Resource Platforms
3
App
1
Online Courses
1
Countries / Regions
Global
77
Western and Central Europe
29
Africa
16
Syria
15
Kenya
15
Ukraine
15
Sierra Leone
14
Myanmar / Burma
14
Latin America and the Carribbean
13
India
12
Zambia
12
Uganda
11
Eastern Europe
11
Liberia
10
Ethiopia
10
Nepal
9
Nigeria
8
Ghana
8
Asia
8
Congo, Democratic Republic of
7
South Sudan
7
Lesotho
7
South–East Asia Region
7
Tanzania
6
Yemen
6
Burkina Faso
5
Haiti
5
East and Southern Africa
5
West and Central Africa
5
Russia
5
Guinea
4
Zimbabwe
4
Jordan
4
Lebanon
4
South Africa
4
Bangladesh
4
Central African Republic
4
Namibia
4
Middle East and North Africa
4
Venezuela
4
Senegal
3
Somalia
3
Afghanistan
3
Germany
3
Cambodia
3
China
3
Rwanda
3
Indonesia
3
Malawi
3
Colombia
3
Eastern Europe and Central Asia
3
Georgia
3
USA
2
Cameroon
2
Niger
2
Pakistan
2
Thailand
2
Mozambique
2
Eswatini/ Swaziland
2
Sri Lanka
2
Albania
2
Iran
2
Vietnam
2
Mali
1
Philippines
1
Egypt
1
Ireland
1
Papua New Guinea
1
Sudan
1
Benin
1
Peru
1
Switzerland
1
Burundi
1
Ecuador
1
Bolivia
1
Libya
1
Guatemala
1
Mexico
1
Western Pacific Region
1
Paraguay
1
Poland
1
Palestine
1
Southern Africa
1
Laos
1
Canada
1
Estonia
1
Romania
1
Moldova
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
192
Public Health
81
Clinical Guidelines
69
Women & Child Health
36
Key Resources
36
Capacity Building
11
Pharmacy & Technologies
7
Toolboxes
Mental Health
113
HIV
84
COVID-19
75
Planetary Health
69
Disability
55
TB
46
Global Health Education
44
AMR
44
Health Financing Toolbox
37
NCDs
34
Conflict
27
Rapid Response
21
Caregiver
21
Refugee
20
Pharmacy
20
Ebola
16
NTDs
14
Polio
7
Natural Hazards
7
Cholera
4
Social Ethics
4
Zika
3
Specific Hazards
2
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive national suicide prevention strategy. Governments and communities can ...
Навчальні та методичні модулі ініціативи ВООЗ QualityRights було розроблено з метою покращення знань, навичок та розуміння ключових зацікавлених сторін про те, як сприя...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the ... of users as well as to others and society at large. It provides WHO recommendations for the most effective prevention measures in Viet Nam and will also help answer questions that policy makers may have on how to develop effective policies for prevention and control of alcohol related harms.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicabl...
Plus de 700 000 personnes perdent la vie par suicide chaque année. La réduction d’un tiers du taux mondial de mortalité par suicide d’ici à 2030 est à la fois un indicateur et une cible (la seule pour la santé mentale) dans les objectifs de développement durable des Nations Unies et dans ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundament...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
